(All fields required)
Please enter a valid email.
Please enter your name.
Jeffrey B. Anderson, MD, MPH
is an electrophysiologist with a clinical interest in heart rhythm abnormalities and syncope in pediatric patients. His has a research interest in quality improvement and outcomes in infants and children with congenital heart disease. He is currently working on projects to improve medical management of pediatric patients presenting with syncope as well as to improve nutrition and growth in infants with complex congenital heart disease.
Assistant Professor, UC Department of Pediatrics
Pediatric electrophysiology; Syncope; Quality improvement and outcomes
Syncope, nutrition and growth in congenital heart disease, large database analysis, quality improvement
Jeffrey B. Anderson MD, MPH, is an assistant professor of pediatrics with the University of Cincinnati College of Medicine and holds a joint appointment with the Heart Institute and the James M. Anderson Center for Clinical Excellence at Cincinnati Children’s Hospital Medical Center.
Dr. Anderson obtained both his medical degree and his Masters in Public Health from the University of Utah School of Medicine. He completed an internship in internal medicine and pediatrics at the North Carolina Memorial Hospital followed by a pediatrics residency at the North Carolina Children’s Hospital in Chapel Hill, NC. Following a year serving as pediatric chief resident in Chapel Hill, he completed his pediatric cardiology fellowship and advanced training in electrophysiology at Cincinnati Children’s Hospital Medical Center.
Dr. Anderson’s research interests include nutrition in congenital heart disease, syncope in the pediatric population and application of quality improvement methodology to improve outcomes in congenital heart disease. Dr. Anderson has spent the last several years working with infants with congenital heart disease with nutritional failure to better understand the etiology of their growth problems and to design interventions to improve their growth.
Following cardiology fellowship, Dr. Anderson helped establish the Syncope Clinic in the Heart Institute at Cincinnati Children’s Hospital Medical Center, and he continues to direct the work in this clinic.
Anderson JB, Kalkwarf HJ, Kehl JE, Eghtesady P, Marino BS. Low Weight-for-Age Z-Score and Infection Risk After the Fontan Procedure. Ann Thorac Surg. 2011 May;91(5):1460-6.
Anderson JB, Marino BS, Irving SY, García-España JF, Ravishankar C, Stallings VA, Medoff-Cooper B. Poor post-operative growth in infants with two-ventricle physiology. Cardiol Young. 2011 Mar 9:1-9.
Anderson JB, Benson DW. Genetics of sick sinus syndrome. Card Electrophysiol Clin. 2010 Dec 1;2(4):499-507.
Czosek RJ, Anderson JB, Cao J, Knilans TK. Assessment of T-wave oversensing in an infant with an implanted defibrillator. Heart Rhythm. 2010 Oct;7(10):1516-7.
Anderson JB, Beekman RH 3rd, Eghtesady P, Kalkwarf HJ, Uzark K, Kehl JE, Marino BS. Predictors of poor weight gain in infants with a single ventricle. J Pediatr. 2010 Sep;157(3):407-13, 413.e1. Dixon CA, Anderson JB, Ruddy RM, Cripe LH. Infantile-onset Pompe disease: a diagnosis not to miss. Pediatr Emerg Care. 2010 Apr;26(4):293-5. Anderson JB, Beekman RH 3rd, Border WL, Kalkwarf HJ, Khoury PR, Uzark K, Eghtesady P, Marino BS. Lower weight-for-age z score adversely affects hospital length of stay after the bidirectional Glenn procedure in 100 infants with a single ventricle. J Thorac Cardiovasc Surg. 2009 Aug;138(2):397-404.e1.
Anderson J, Kocis K. Echocardiographic evaluation of pericardial effusions and cardiac tamponade in children. Pediatric Ultrasound Today. 2006; 11(8): 137-52. Anderson JB, Fuller TC, Hawkins JA, Brinkman MK, Profaizer T, Shaddy MD. Long-term reduction of panel reactive antibodies in children receiving mycophenolate mofetil after valved allograft placement. Transplantation. 2005 Aug 15;80(3):414-6. Shaddy RE, Fuller TC, Anderson JB, Lambert LM, Brinkman MK, Profaizer T, Hawkins JA. Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation. Ann Thorac Surg. 2004 May;77(5):1734-9.
Robert H. Beekman, III, MD
Professor, UC Department of Pediatrics
Cardiac catheterization; intervention for congenital heart disease; quality improvement
Robert H. Beekman, III, MD, is currently a professor of Pediatric Cardiology at Children's Hospital Medical Center of Cincinnati, Ohio. Dr. Beekman's subspecialty interests involve cardiac catheterization and interventional cardiology, and clinical quality improvement.
A native of California, Dr. Beekman graduated from Occidental College in Los Angeles, and earned his MD from Duke University in Durham, NC. Dr. Beekman completed his pediatric internship and residency at UCLA Medical Center, and his pediatric cardiology fellowship at the University of Michigan Medical Center, Ann Arbor, MI. Dr. Beekman also obtained a Master's Degree in Statistical Analysis and Research Design from the University of Michigan. From 1985 to 1996, Dr. Beekman was a member of the Division of Pediatric Cardiology at the University of Michigan School of Medicine. From 1996-2006 he was Director of Cardiology at Children's Hospital Medical Center of Cincinnati, and professor of Pediatrics at the University of Cincinnati School of Medicine.
Dr. Beekman's academic interests relate to cardiac catheterization, and he has made numerous scholarly contributions in the field of hemodynamic assessment and transcatheter intervention for congenital heart disease. He has published more than 170 manuscripts in cardiology journals.
Dr. Beekman has been active in the cardiology community, locally and nationally. He is Chair of the Section on Cardiology and Cardiac Surgery of the American Academy of Pediatrics. Beekman also is the Chair of the JCCHD National Quality Improvement Collaborative for pediatric cardiology. Dr. Beekman has been a member of the Executive Committee and the Training Committee of the AHA Council on Cardiovascular Disease in the Young, and of the Congenital Heart Committee of the ACC. He is currently on the editorial board of the Journal of Interventional Cardiology, a contributing editor of theHeart.org, an Internet cardiology journal, and an associate editor of Congenital Heart Disease.
MD: Duke University School of Medicine, Durham, NC, 1976.
MS: Clinical Research Design and Statistics, University of Michigan, Ann Arbor, MI, 1986.Residency: Pediatrics, UCLA Medical Center, Los Angeles, CA, 1976 to 1979.Fellowship: Pediatric Cardiology, CS Mott Children's Hospital, University of Michigan, Ann Arbor, MI, 1979 to 1982.Certification: Pediatrics, 1981; Pediatric Cardiology, 1983.
Anderson JB, Beekman RH 3rd, Eghtesady P, Kalkwarf HJ, Uzark K, Kehl JE, Marino BS. Predictors of poor weight gain in infants with a single ventricle. J Pediatr. 2010 Sep;157(3):407-13, 413.e1. Sutherell JS, Hirsch R, Beekman RH 3rd. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices. Congenit Heart Dis. 2010 Jan;5(1):2-7.
Anderson JB, Beekman RH 3rd, Border WL, Kalkwarf HJ, Khoury PR, Uzark K, Eghtesady P, Marino BS. Lower weight-for-age z score adversely affects hospital length of stay after the bidirectional Glenn procedure in 100 infants with a single ventricle. J Thorac Cardiovasc Surg. 2009 Aug;138(2):397-404.e1. Beekman RH 3rd, Duncan BW, Hagler DJ, Jones TK, Kugler JD, Moore JW, Jenkins KJ; Workgroup on Pediatric Cardiac Devices, Section on Cardiology and Cardiac Surgery, American Academy of Pediatrics. Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions. Pediatrics. 2009 Jul;124(1):e155-62. Bennett MR, Ravipati N, Ross G, Nguyen MT, Hirsch R, Beekman RH, Rovner L, Devarajan P. Using proteomics to identify preprocedural risk factors for contrast induced nephropathy. Proteomics Clin Appl. 2008;2(7-8):1058-1064.
Cooper DS, Jacobs JP, Chai PJ, Jaggers J, Barach P, Beekman RH, Krogman O, Manning P. Pulmonary complications associated with the treatment of patients with congenital heart disease: Consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiology in the Young. 2008;18:215-221.
Jenkins KJ, Beekman RH, Bergersen LJ, Everett AD, Forbes TJ, Franklin RCG, Klitzner TS, Krogman ON, Martin GR, Webb CL. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease: The perspective of cardiology. Cardiology in the Young. 2008;18:116-123, 2008.
Mays WA, Border WL, Knecht SK, Gerdes YM, Pfriem H, Claytor RP, Knilans TK, Hirsch R, Mone SM, Beekman RH. Exercise capacity improves after transcatheter closure of the Fontan fenestration in children. Congenital Heart Disease. 2008;3: 254-261.
Gudausky TM, Hirsch R, Khoury PR, Beekman RH: Comparison of two transcatheter device strategies for occlusion of the patent ductus arteriosus. Catheter Cardiovasc Interven. 2008;72: 675-680.
Gruenstein DH, Beekman RH, Spicer RL Ductal stent and cavo-atrial sac occlusion in an adult with profound cyanosis after palliated cyanotic congenital heart disease. residual superior vena caval-right atrial shunt in an adult with palliated complex congenital heart disease. J Invasive Cardiol. 2008;20: E41-43.
Burns C. Blaxall, PhD, FAHA Director of Translational Science, Heart Institute
is interested in understanding the molecular mechanisms associated with the development and progression of heart failure. We are particularly interested in developing novel heart failure therapeutics targeting myocardial function and fibrosis. To this end, we also seek to understand the pathologic role of cardiac myocyte and non-myocyte (i.e.. fibroblast) intercellular communication.
Director of Translational Science, Heart Institute
Molecular and signaling mechanisms of heart failure; cardiac fibrosis; drug and therapeutic discovery
Dr. Burns C. Blaxall has focused his entire career on understanding the molecular mechanisms of heart failure. He received his PhD in Pharmacology from the University of Colorado Health Sciences Center, and postdoctoral training at Duke University Medical Center. He then rose through the faculty ranks at the University of Rochester Medical Center and the Aab Cardiovascular Research Institute, where he also directed the Howard Hughes Medical Institute Med-into-Grad Fellowship in Cardiovascular Science.
In 2012, he was recruited to the Heart Institute of Cincinnati Children’s Hospital Medical Center, where he is director of Translational Science. Dr. Blaxall has received many academic honors, including the Early Career Investigator Award from the American Heart Association (AHA), the Outstanding Achievement Award from the Founder’s AHA Affiliate, the Merit Award for Research Achievement from Mended Hearts, and election as Fellow of the AHA.
PhD: University of Colorado HSC, Denver, CO, 1999.
Fellowship: Duke University Medical Center, Durham, NC.
Martin ML, Blaxall BC. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? J Cardiovasc Transl Res. 2012.
Jaffré F, Friedman AE, Hu Z-Y, Mackman N and Blaxall BC. Beta-adrenergic receptor stimulation transactivates Protease-Activated Receptor 1 via MMP-13 in heart. Circulation. 2012;125(24):2993-3003.
Kamal FA, Smrcka AV, Blaxall BC. Taking the heart failure battle inside the cell: Small molecule targeting of Gβγ subunits. J Mol Cell Cardiol. 2011;51(4):462-7.
Ram R, Mickelsen DM, Theodoropoulos C, Blaxall BC. New approaches in small animal echocardiography: imaging the sounds of silence. Amer J Pathol Heart Circ Physiol. 2011;301(5):H1765-80.
Belmonte S, Blaxall BC. G-protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ Res. 2011;109(3):309-19.
Aguilar F, Casey LM, Belmonte S, Noujaim SF, Maekawa N, Dunaevsky O, Protak TL, Noujaim S, Jalife J, Berk BC, Gertler FB, Blaxall BC. Cardiac dysfunction in Mena knockout mice. Amer J Pathol Heart Circ Phys. 2011;300(5):H1841-52.
Casey LM, Pistner AR, Belmonte S, Jaffre F, Migdalovic D, Stolpnik O, Nwakanma F, Vorobiof G, Dunaevsky O, Smrcka AV, Blaxall BC. Small molecule targeting of G beta gamma prevents heart failure progression. Circ Res. 2010;107(4):532-9.
Jaffré F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Monassier L, Mettauer, Blaxall BC, Launay JM, Maroteaux L. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res. 2009;104;113-123.
Bullard TA, Protack TL, Aguilar F, Bagwe S, Massey HT, Blaxall BC. Identification of Nogo as a novel indicator of heart failure. Physiolog Genom. 2008;32(2):182-9.
R, Hampton CR, Casey LM, Bullard TA, Tencati M, Pedersen B, Andrade-Gordon P, Sayen MR, Gottlieb RA, Pohlman TH, Verrier ED, Blaxall BC, Mackman N. Par-1 in Cardiac Remodeling and Heart Failure. Circulation. 2007;116(20):2298-306.
Jonathan W. Byrnes, MD Attending Cardiac Intensivist, Cardiac Intensive Care Unit
is a cardiac intensivist who is active in clinical and translational research involving extracorporeal life support. This research is focused on the biocompatibility of the patient/device interface and the associated interaction of coagulation and inflammatory pathways. The aim of these endeavors is to decrease the incidence of end organ dysfunction and stroke associated with these therapies.
Attending Cardiac Intensivist, Cardiac Intensive Care Unit
Jonathan Byrnes, MD, is an assistant professor of Pediatrics with the University of Cincinnati College of Medicine and an attending cardiac intensivist in Cincinnati Children’s Hospital Medical Center’s Cardiac Intensive Care Unit. He joined the faculty in July 2013.
A native of Mississippi, Dr. Byrnes graduated with Honors from University of Mississippi and earned his medical degree from University of Mississippi Medical Center in 2005. He completed his pediatric residency at Blair Batson Children's Hospital in Jackson, MS and a combined fellowship in Cardiology and Critical Care Medicine at Arkansas Children's Hospital. Dr. Byrnes’s clinical interests are providing superb, cost-effective care and delivering cohesive management amongst all specialties in the cardiac intensive care unit.
Dr. Byrnes, is active in clinical and translational research involving extracorporeal life support that would benefit critically ill children. This research is primarily focused on the biocompatibility of the patient / device interface and the associated interaction of the coagulation and inflammatory pathways. The aim of these endeavors is to ultimately decrease the incidence of end organ dysfunction and stroke associated with these therapies.
MD: University of Mississippi Medical Center, Jackson, MS, 2005.
Residency: Pediatrics, University of Mississippi Medical Center, Jackson, MS, 2008.
Fellowships: Combined Pediatric Cardiology and Pediatric Critical Care Medicine, Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, AR, 2013.
Certification: American Board of Pediatrics, 2008.
Prodhan P, Imamura M, Garcia X, Byrnes J, Bhutta A, Dyamenahalli U. Abdominal Compartment Syndrome in Newborns and Children supported on Extracorporeal Membrane Oxygenation. ASAIO J. 2012;58(2): 143-147.
Byrnes J, Williams B, Prodhan P, Erdem E, Williamson R, Gautam N, James C, Jaquiss R, Imamura M, and Bhutta A. Successful intra-arterial thrombolytic therapy for a right middle cerebral artery stroke in a 2-year old supported by a ventricular assist device. Transpl Int. 2012;25(3): e31-33.
Byrnes J, W McKamie, C Swearingen, Gossett J, Prodhan P, Bhutta A, Jaquiss R, Imamura M, Fiser R. Hemolysis during Cardiac Extracorporeal Membrane Oxygenation: A Case-Control Comparison of a Roller Pump and a Centrifugal Pump in a Pediatric Population. ASAIO J. 2011 Sep-Oct;57(5):456-61.
Byrnes J, Prodhan P, Imamura M, Frazier E. Accidental Azygos Vein Extracorporeal Membrane Oxygenation Cannulation in a Neonate with Premature Closure of the Ductus Arteriosus. ASAIO J. 2011 Jul-Aug; 57(4): 344-5.
James F. Cnota, MD
is a pediatric cardiologist with clinical focus in echocardiography and fetal cardiology. His research activities are in two areas: 1) fetal cardiology and perinatal risk factors in congenital heart disease and 2) multicenter clinical trials in pediatric cardiovascular disease.
Associate Professor, UC Department of Pediatrics
Fetal cardiology including fetal echocardiography
Impact of insulin sensitivity on left ventricular mass in healthy teens; blood pressure in offspring of preeclamptic mothers; fetal programming of cardiovascular outcomes; multicenter trials in pediatric heart disease
BS: Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, 1991
MD: Tulane University School of Medicine, New Orleans, Louisiana, 1995
Residency: University of Arizona Health Sciences Center, Tucson, Arizona, 1998
Fellowship: Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2001
MS: Clinical Epidemiology and Health Services Research, Wake Forest University School of Medicine, Winston-Salem, North Carolina, 2005
Divanović A, Hor K, Cnota J, Hirsch R, Kinsel-Ziter M, Michelfelder E. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: Clinical experience using pulmonary venous Doppler analysis. J Thorac Cardiovasc Surg. 2010 Dec 2. Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation. Am J Obstet Gynecol. 2010 Oct;203(4):397.e1-9. Habli M, Cnota J, Michelfelder E, Salisbury S, Schnell B, Polzin W, Lim FY, Crombleholme TM. The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2010 Oct;203(4):404.e1-7. Hambrook JT, Kimball TR, Khoury P, Cnota J. Disparities exist in the emergency department evaluation of pediatric chest pain. Congenit Heart Dis. 2010 May-Jun;5(3):285-91. Vuletin JF, Lim FY, Cnota J, Kline-Fath B, Salisbury S, Haberman B, Kingma P, Frischer J, Crombleholme T. Prenatal pulmonary hypertension index: novel prenatal predictor of severe postnatal pulmonary artery hypertension in antenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 2010 Apr;45(4):703-8. Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung ES, Benson DW, Mazur W. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging. 2010 Feb;3(2):144-51. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005 Jan;115(1):178-81.
Grace BE, Cnota JF, Hines MH, Payne RM, Ririe DO. Traumatic Coronary Artery Fistula in a Child. Circulation 2005;1 II :e272-e273.
David S. Cooper, MD, MPH Director, Cardiac Extracorporeal Life Support Program
has clinical and research interests that relate to many aspects of cardiac intensive care, including fluid overload and acute kidney injury in critical illness; near infrared spectroscopy in the CVICU; early extubation after neonatal and infant congenital heart surgery; impact of gestational age on outcome; and analysis of morbidity/mortality in patients with congenital heart disease.
Director, Cardiac Extracorporeal Life Support Program
Associate Director, Cardiovascular Intensive Care Unit
MD: University of South Florida College of Medicine, Tampa, Florida, 1996.
MPH: University of South Florida College of Public Health, Tampa, Florida, 1999.
Residency: All Children’s Hospital, University of South Florida, St. Petersburg, FL.
Fellowships: Cardiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; Critical Care, Children’s Medical Center Dallas, UT Southwestern, Dallas, Texas.
Certifications: American Board of Pediatrics; American Board of Pediatrics, Sub-board of Pediatric Cardiology; American Board of Pediatrics, Sub-board of Pediatric Critical Care.
Cooper DS, Charpie JR, Flores FX, Gaynor JW, Salvin JW, Devarajan P, Krawczeski CD. Acute kidney injury and critical cardiac disease. World J Ped Congen Heart Surg. 2011;2:411-423. Jacobs JP, Asante-Korang A, O'Brien SM, Chai PJ, Dadlani GH, Rodriguez-Fazzi GL, Vu D, McCormack J, McKenna DE, Boucek RJ Jr, Cooper DS, Saltiel A, Carapellucci J, van Gelder HM, Daicoff GR, Quintessenza JA. Lessons learned from 119 consecutive cardiac transplants for pediatric and congenital heart disease. Ann Thorac Surg. 2011 Apr;91(4):1248-54. Pilchard J, Dadlani G, Andropoulos D, Jacobs JP and Cooper DS. Intensive care and perioperative management of patients with complete atrioventricular septal defect . World J Ped Congen Heart Surg. 2010 Apr;1:105-111.
Scanlon MC, Ghanayem NS, Atz AM, Cooper DS. Innovation in congenital and paediatric cardiac critical care. Cardiol Young. 2009 Nov;19 Suppl 2:85-9. Cooper DS, Costello JM, Bronicki RA, Stock AC, Jacobs JP, Ravishankar C, Dominguez TE, Ghanayem NS. Current challenges in cardiac intensive care: optimal strategies for mechanical ventilation and timing of extubation. Cardiol Young. 2008 Dec;18 Suppl 3:72-83. Cooper DS, Jacobs JP, Chai PJ, Jaggers J, Barach P, Beekman RH, Krogmann O, Manning P. Pulmonary complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008 Dec;18 Suppl 2:215-21. Bacha EA, Cooper D, Thiagarajan R, Franklin RC, Krogmann O, Deal B, Mavroudis C, Shukla A, Yeh T, Barach P, Wessel D, Stellin G, Colan SD. Cardiac complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008 Dec;18 Suppl 2:196-201. Cooper DS, Jacobs JP, Moore L, Stock A, Gaynor JW, Chancy T, Parpard M, Griffin DA, Owens T, Checchia PA, Thiagarajan RR, Spray TL, Ravishankar C. Cardiac extracorporeal life support: state of the art in 2007. Cardiol Young. 2007 Sep;17 Suppl 2:104-15. Cooper, D.S. and Nichter M.A. Advances in cardiac intensive care. Curr Opin Ped. 2006 Oct;18(5):503-11.Cooper DS, Schwartz SM, Raake JL, Beam AR, Nelson DP. Supplemental inhaled gases alter tidal volume delivery and measurement. Pediatr Crit Care Med. 2005 Mar;6(2):150-3.
Allison A. Divanovic, MD
is a pediatric cardiologist who specializes in noninvasive imaging, specifically transthoracic and fetal echocardiography. Her research interests include the impact of Twin-twin transfusion syndrome on the fetal heart as well as the management of fetuses with congenital heart defects, in particular, hypoplastic left heart syndrome.
Bryan H. Goldstein, MD
is an interventional pediatric cardiologist with a clinical focus on minimally invasive and hybrid transcatheter therapies for complex congenital and structural heart disease. His research interests include novel transcatheter interventions (including fetal therapy), long-term outcomes following interventions for congenital heart disease, long-term functional outcomes following Fontan palliation for single ventricle physiology, and investigations of vascular function in repaired or palliated CHD patients.
Cardiac catheterization; intervention for congenital heart disease; transcatheter valve implantation; single ventricle physiology
Bryan H. Goldstein, MD joined the Heart Institute in August 2011 in the section of cardiac catheterization and intervention. He was previously a clinical lecturer at the University of Michigan where he completed fellowship training.
A native of Boston, MA, Dr. Goldstein graduated with Distinction and Honors from Amherst College, where he was a goalie on the men's lacrosse team. He earned his medical degree with Honors from Boston University School of Medicine. He completed his pediatric internship and residency in the Boston Combined Residency in Pediatrics (Children's Hospital Boston) and his pediatric cardiology and interventional cardiology fellowships at the University of Michigan (C.S. Mott Children's Hospital) in Ann Arbor, MI.
Dr. Goldstein’s clinical expertise is in congenital cardiac catheterization. He is interested in invasive physiologic assessment of complex congenital heart disease, including single ventricle physiology, as well as minimally invasive transcatheter therapies. Dr. Goldstein is also interested in furthering hybrid therapies offered for congenital heart disease in patients both young and old.
Dr. Goldstein’s research interests include novel transcatheter interventions (including fetal therapy) and long-term outcomes following interventions for congenital heart disease. An additional research focus includes long-term functional outcomes following Fontan palliation for single ventricle physiology. Dr. Goldstein previously served as a co-investigator for the Melody™ Transcatheter Pulmonary Valve Post-Approval Study.
Dr. Goldstein is an active member of the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, and American Academy of Pediatrics.
MD: Boston University School of Medicine, Boston, MA, 2004.
Residency: Pediatrics, Children’s Hospital Boston, Boston, MA, 2007.
Fellowship: Pediatric Cardiology, C.S. Mott Children’s Hospital, Ann Arbor, MI, 2010.
Advanced Fellowship: Interventional Cardiology, C.S. Mott Children’s Hospital, Ann Arbor, MI, 2011.
Certifications: Pediatrics, 2007; Pediatric Cardiology, 2010.
Goldstein BH, Golbus JR, Sandelin AM, Warnke N, Gooding L, King KK, Donohue JE, Yu S, Gurney JG, Goldberg CS, Rocchini AP, Charpie JR. Impact of Vitamin C on Endothelial Function and Exercise Capacity in Patients with a Fontan Circulation. Congenit Heart Dis. 2011.
Goldstein BH, Aiyagari R, Bocks ML, Armstrong AK. Hydrogel Expandable Coils for Vascular Occlusion in Congenital Cardiovascular Disease: A Single Center Experience. Congenit Heart Dis. 2011.
Goldstein BH, Fifer CG, Armstrong AK, Gelehrter SK, Treadwell MC, van de Ven C, Rocchini AP. Use of a Pressure Guidewire in Fetal Cardiac Intervention for Critical Aortic Stenosis. Pediatrics. 2011 Aug 15.
Schumacher KR, Cools M, Goldstein BH, Ioffe-Dahan V, King K, Gaffney D, Russell MW. Oral Budesonide Treatment for Protein Losing Enteropathy in Fontan-Palliated Patients. Pediatr Cardiol. 2011 Oct;32(7):966-71.
Goldstein BH, Golbus JR, Sandelin AM, Warnke N, Gooding L, King KK, Donohue JE, Gurney JG, Goldberg CS, Rocchini AP, Charpie JR. Usefulness of Peripheral Vascular Function to Predict Functional Health Status in Patients with a Fontan Circulation. Am J Cardiol. 2011 Aug 1;108(3):428-34.
Goldstein BH, Bergersen L, Powell AJ, Graham D, Bacha E, Lang P. Long-Term Outcome of Surgically Repaired Unilateral Anomalous Pulmonary Artery Origin. Pediatr Cardiol. 2010 Oct;31(7):944-51.
Goldstein BH, Connor C, Gooding L, Rocchini AP. Relation of Systemic Venous Return, Diastolic Dysfunction and Pulmonary Vascular Resistance to Exercise Capacity in Patients with Single Ventricle Receiving Fontan Palliation. Am J Cardiol. 2010 Apr 15;105(8):1169-75.
Stuart L. Goldstein, MD Director, Center for Acute Care Nephrology
Director, Center for Acute Care Nephrology
Acute kidney injury; continuous renal replacement therapy; end-stage renal disease; health-related quality of life
Acute kidney injury epidemiology and biomarkers; health-related quality of life in ESRD; cardiovascular complications and inflammation in ESRD
Stuart L. Goldstein, MD has been an active investigator in the field of pediatric acute kidney injury (AKI) since 2000. Dr. Goldstein's main research foci include AKI epidemiology and outcomes, acute renal replacement therapy provision and investigation of novel urinary AKI biomarkers in the pediatric population. Dr. Goldstein has a strong record of interdisciplinary and inter-institutional collaboration, evidenced by his establishment and directing of the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) and its success as well as collaboration with critical care physicians, cardiologists and emergency medicine physicians to study AKI in their populations.
This collaboration includes publication of the first article demonstrating the existence of a cardio-renal syndrome in pediatric patients with acute decompensated heart failure. Dr. Goldstein has also performed the only published assessment of novel urinary AKI biomarkers in a heterogeneous group of critically ill children, demonstrating their accuracy to predict AKI development and severity. Dr. Goldstein has been developing a program to investigate and minimize nephrotoxic medication associated AKI in non-critically ill children.
Goldstein SL, Devarajan P. Acute kidney injury in childhood: should we be worried about progression to CKD? Pediatr Nephrol. 2011 Apr;26(4):509-22.
Du Y, Zappitelli M, Mian A, Bennett M, Ma Q, Devarajan P, Mehta R, Goldstein SL. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center. Pediatr Nephrol. 2011 Feb;26(2):267-74.
Moffett BS, Goldstein SL, Adusei M, Kuzin J, Mohan P, Mott AR. Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med. 2011 Feb 10.
Zappitelli M, Moffett BS, Hyder A, Goldstein SL. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant. 2011 Jan;26(1):144-50.
Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, Askenazi D. Acute Kidney Injury Reduces Survival in Very Low Birth Weight Infant. Pediatr Res. 2010 Dec 20.
Goldstein SL. Continuous renal replacement therapy: mechanism of clearance, fluid removal, indications and outcomes. Curr Opin Pediatr. 2010 Dec 21.
Goldstein SL. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? Kidney Int. 2010 Sep;78(5):433-5.
Goldstein SL, Chawla L. Renal Angina. Clin J AmSoc Nephrol. 2010 May;5(5):943-9.
Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJG, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL. Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry. Am J Kidney Dis. 2010 Feb;55(2):316-25.
PlasmaLyte Gastroenteritis Study. Principal Investigator. Baxter Healthcare. Nov 2010 - Oct 2011.
Inflammation, malnutrition and cardiac calcification in pediatric ESRD patients receiving dialysis- a comparison of hemodialysis vs. peritoneal dialysis. Principal Investigator. Baxter Healthcare. Dec 2010 - Dec 2011.
Optimize Fluid Dosing in Critically Ill Children with Acute Kidney Injury. Principal Investigator. Casey Lee Ball Foundation. Jan 2011 – Dec 2011.
Use of NGAL to Optimize Fluid Dosing, CRRT Initiation and Discontinuation in Critically Ill Children with Acute Kidney Injury. Principal Investigator. Casey Lee Ball Foundation. Feb 2011 - Jan 2012.
Evaluation of cystatin C and Urine Proteins as Early Biomarkers of AKI in Children Treated with Nephrotoxic Medication. Principal Investigator. The Research Institute of McGill University Health Centre. Jun 2011 – Jun 2012.
Center for Acute Care Nephrology Fellowship. Fellowship Director. Funded by Gambra Renal Products. Jan 2011 - Jan 2013.
Inflammation, malnutrition and cardiac calcification in pediatric ESRD patients receiving dialysis. Principal Investigator. Casey Lee Ball Foundation. Jan 2010 - Dec 2020.
Robert Bruce Hinton, MD Director, Cardiovascular Genetics
Director, Cardiovascular Genetics
Director, Heart Institute BioRepository (HIBR)
Cardiovascular genetics; echocardiography
Valve and aorta disease using human genetics and molecular developmental biology approaches
Dr. Hinton graduated from Bucknell University with degrees in Art History and Philosophy. He earned his medical degree from the Medical University of South Carolina in Charleston SC. He completed his pediatric residency training at Memorial Health University Medical Center in Savannah GA and his pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Hinton went on to pursue a postdoctoral fellowship in Cardiovascular Genetics and Molecular Cardiology at Cincinnati Children’s. He has been an attending staff member of the Division of Cardiology since 2006.
Dr. Hinton’s clinical interests relate to cardiovascular genetics and echocardiography. He is a member of the cardiovascular genetics service, and staffs the echocardiography laboratory. Dr. Hinton’s academic interests focus on translational research efforts using mouse models of human disease to identify new therapeutic targets. Dr. Hinton is a member of the American Academy of Pediatrics, the American Heart Association, the American Society of Bioethics and Humanities, and the American Society of Matrix Biology. He was elected to the Society for Pediatric Research in 2007.
Krishnamurthy VK, Opoka A, Kern CB, Guliak F, Narmoneva DA, Hinton RB. Regional Maladaptive Matrix Remodeling and Biomechanical Dysfunction in a Mouse Model of Aortic Valve Disease. Matrix Biology. 2012; 31(3):197-205. PMID: 22265892.
Kindel SJ, Miller EM, Gupta R, Cripe LH, Hinton RB, Spicer RL, Towbin JA, Ware SM. Pediatric Cardiomyopathy: Importance of Genetic and Metabolic Evaluation. Journal of Cardiac Failure. 2012; 18(5):396-403. PMID: 22555271.
Ryan TD, Ware SM, Lucky AW, Towbin JA, Jefferies JL, Hinton RB. Left Ventricular Noncompaction Cardiomyopathy and Aortopathy in a Patient with Recessive Dystrophic Epidermolysis Bullosa. Circulation Heart Failure. 2012; 5(5):81-82. PMID: 22991407.
Georg-Abraham JK, Zimmerman SL, Hinton RB, Marino BS, Witte D, Hopkin RJ. Tetrasomy 15q25-qter Identified with SNP Microarray in a Patient with Multiple Anomalies including Complex Cardiovascular Malformation. American Journal of Medical Genetics. 2012; 158A(8):1971-1976. PMID: 22711292.
Hinton RB. Bicuspid Aortic Valve and Thoracic Aortic Aneurysm: Three Patient Populations, Two Disease Phenotypes, One Shared Genotype. Cardiology Research and Practice. 2012. 926975. PMID: 22970404.
Krishnamurthy VK, Guliak F, Narmoneva DA, Hinton RB. Regional structure-function relationships in mouse aortic valve tissue. J Biomech. Jan 2011;44(1):77-83.
Wirrig EE, Hinton RB, Yutzey KE. Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J Mol Cell Cardiol. Mar 2011;50(3):561-569.
Calloway TJ, Martin LJ, Zhang X, Tandon A, Benson DW, Hinton RB. Risk factors for aortic valve disease in bicuspid aortic valve: a family-based study. Am J Med Genet A. May 2011;155A(5):1015-1020.
Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Reb Physiol. Mar 2011;73:29-46.
Martin LJ, Hinton RB, Zhang X, Cripe LH, Benson DW. Aorta measurements are heritable and influenced by bicuspid aortic valve. Frontiers in Genetics. 2011;2(61).
Angiogenesis Inhibition Therapy for Aortic Valve Disease. Principal Investigator. National Center for Research Resources (NIH/NCRR). Jul 2011-Jun 2012.
Twist1 regulation of valve progenitors. Co-Investigator. National Heart, Lung and Blood Institute (NIH/NHLBI). Jul 2010-Jun 2015.
Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan). Co-Investigator. National Heart, Lung and Blood Institute (NIH/NHLBI) Pediatric Heart Network. Sept 2006-Aug 2016.
Aortic root structure-function relationships in a mouse model of aortic valve disease and aortopathy. Supervisor. American Heart Association, Great Rivers Affiliate. Jul 2011-Jun 2012.
John Lynn Jefferies, MD, MPH, FAAP, FACC Director, Advanced Heart Failure and Cardiomyopathy
is a clinical cardiologist who has translational and clinical research programs. His research involves cardiomyopathy and cardiovascular genetics with specific interest in dystrophinopathies and aortopathies in children and adults. He also has clinical research projects investigating novel biomarkers of heart failure, chemotherapy induced cardiotoxicity, and the cardiorenal syndrome.
Director, Advanced Heart Failure and Cardiomyopathy
Dr. Jefferies, an associate professor of pediatric cardiology and adult cardiovascular diseases, is the director of Advanced Heart Failure / Cardiomyopathy within The Heart Institute at Cincinnati Children's Hospital Medical Center.
He completed his combined pediatric and adult cardiology training at the Baylor College of Medicine in Houston, Texas at the Texas Children's Hospital and the Texas Heart Institute. He has authored or co-authored over 100 peer-reviewed manuscripts and book chapters on cardiomyopathy, cardiovascular genetics, and adults with congenital heart disease.
His current research interests include heritable causes of vascular disease, novel drug therapies for advanced heart failure, novel gene discovery in cardiomyopathy, characterization and management of left ventricular noncompaction (LVNC), and early diagnosis and management of chemotherapy induced cardiotoxicity.
He is on the editorial board of the Texas Heart Institute Journal and is an active member of numerous professional organization including the Heart Failure Society of America, the American College of Cardiology and the American Heart Association.
Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010 Feb;375(9716):752-62. Breinholt JP, Moulik M, Dreyer WJ, Denfield SW, Kim JJ, Jefferies JL, Rossano JW, Gates CM, Clunie SK, Bowles KR, Kearney DL, Bowles NE, Towbin JA. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J Heart Lung Transplant. 2010 Jul;29(7):739-46. Rossano JW, Morales DL, Zafar F, Denfield SW, Kim JJ, Jefferies JL, Dreyer WJ. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2010 May 26.
Carlson P, Jefferies JL, Kearney D, Russell H. Refractory dilated cardiomyopathy associated with metastatic neuroblastoma. Pediatr Blood Cancer. 2010 Jun 29.
Shah AM, Jefferies JL, Rossano JW, Decker JA, Cannon BC, Kim JJ. Electrocardiographic abnormalities and arrhythmias are strongly associated with the development of cardiomyopathy in muscular dystrophy. Heart Rhythm. 2010 Jun 18. Moulik M, Breinholt JP, Dreyer WJ, Kearney DL, Price JF, Clunie SK, Moffett BS, Kim JJ, Rossano JW, Jefferies JL, Bowles KR, O'Brian Smith E, Bowles NE, Denfield SW, Towbin JA. Viral Endomyocardial Infection Is an Independent Predictor and Potentially Treatable Risk Factor for Graft Loss and Coronary Vasculopathy in Pediatric Cardiac Transplant Recipients. J Am Coll Cardiol. 2010 56:582-592.Shchelochkov OA, Li FY, Wang J, Zhan H, Towbin JA, Jefferies JL, Wong LJ, Scaglia F. Milder Clinical Course of Type IV 3-Methylglutaconic Aciduria Due to a Novel Mutation in TMEM70. Mol Genet Metab. 2010 101:282-285. Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, Kantor PF, Alvarez JA, Colan SD, Jefferies JL, Lamour JM, Margossian R, Messere JE, Rusconi PG, Shaddy RE, Towbin JA, Wilkinson JD, Lipshultz SE. Ventricular Remodeling and Survival are More Favorable for Myocarditis than for Idiopathic Dilated Cardiomyopathy in Childhood: An Outcomes Study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010. Jefferies JL, Price JF, Morales DL. Mechanical support in childhood heart failure. Heart Fail Clin. 2010 Oct;6(4):559-73. Jefferies JL, Hoffman TM, Nelson DP. Heart failure treatment in the intensive care unit in children. Heart Fail Clin. 2010 Oct;6(4):531-58.
Thomas R. Kimball, MD Medical Director, Heart Institute
is a clinical cardiologist who has clinical research interests in the impact of systemic diseases (including renal, pulmonary and hematologic) on cardiovascular structure and function. He has studied the impact of pediatric obesity on both cardiac and arterial anatomy and physiology and directs the Cardiovascular Imaging Core Research Laboratory which is active in using echocardiography to cardiac phenotype transgenic mice models.
Medical Director, Heart Institute
Congential heart disease; echocardiography; cardiac imaging
Ventricular function; transgenic mice phenotyping; cardiovascular changes with obstructive sleep apnea; cardiovascular changes with renal disease; pediatric obesity; cardiovascular changes in fit and unfit children; echocardiography quality assurance
Thomas R. Kimball, MD, is a professor of pediatrics with the University of Cincinnati College of Medicine and is currently the medical director of the Heart Institute at Cincinnati Children's Hospital Medical Center.
A native of California, Dr. Kimball graduated with Distinction and Honors from Stanford University. He earned his medical degree from New York University, New York, NY. He completed his pediatric internship and residency at Children's Hospital of Los Angeles and his pediatric cardiology fellowship at Cincinnati Children's Hospital Medical Center.
Dr. Kimball has been an attending staff member of the Division of Cardiology at Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine since 1988.
Dr. Kimball's academic interests relate to echocardiography and he has made numerous scholarly contributions in the field of ventricular function utilizing echocardiography, particularly in the field of hypertension and obesity.
He has established collaborative relationships with basic scientists at the University of Cincinnati College of Medicine using echocardiography to evaluate phenotypes of transgenic mice, including embryonic mice.
Dr. Kimball has been active in the cardiology community. He is a member of the American Society of Echocardiography, American Heart Association, American Academy of Pediatrics, American College of Cardiology and an investigator in the NIH Pediatric Heart Network. He was also a member of the first Family Advisory Council at Cincinnati Children's and received the 2006 Family Advisory Council Award of Excellence. In 2010, he was made the Medical Director of the Heart Institute at Cincinnati Children's Hospital.
Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). 2011 May;13(5):332-42.
Urbina EM, Dolan LM, McCoy CE, Khoury PR, Daniels SR, Kimball TR. Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr. 2011 May;158(5):715-21.
Shah AS, Dolan LM, Gao Z, Kimball TR, Urbina EM. Clustering of risk factors: a simple method of detecting cardiovascular disease in youth. Pediatrics. 2011 Feb;127(2):e312-8.
Crowley DI, Khoury PR, Urbina EM, Ippisch HM, Kimball TR. Cardiovascular Impact of the Pediatric Obesity Epidemic: Higher Left Ventricular Mass is Related to Higher Body Mass Index. J Pediatr. 2010 Dec 11.
Shah AS, Khoury PR, Dolan LM, Ippisch HM, Urbina EM, Daniels SR, Kimball TR. The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults. Diabetologia. 2010 Nov 18.
Urbina EM, Kimball TR, Khoury PR, Daniels SR, Dolan LM. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010 Aug;28(8):1692-8.
Sekar P, Border WL, Kimball TR, Hirsch R, Manning PB, Khoury PR, Beekman Iii RH. Aortic arch recoarctation after the Norwood stage I palliation: the comparative accuracy of blood pressure cuff and echocardiographic Doppler gradients in detecting significant obstruction. Congenit Heart Dis. 2009 Nov;4(6):440-7.
Warden CN, Bernard PK, Kimball TR. The efficacy and safety of oral pentobarbital sedation in pediatric echocardiography. J Am Soc Echocardiogr. 2010 Jan;23(1):33-7.
Ippisch HM, Kimball TR. Anomalous origin of the right coronary artery from the left ventricle. J Am Soc Echocardiogr. 2010 Feb;23(2):222.e1-2.
Shah AS, Dolan LM, Kimball TR, Gao Z, Khoury PR, Daniels SR, Urbina EM. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009 Oct;94(10):3740-5.
Shelley Kirk, PhD, RD, LD Director, HealthWorks!, Center for Better Health and Nutrition, Heart Institute
is a clinical dietitian specializing in the assessment and treatment of obese youth and their families. With her doctorate in epidemiology, her research interests are focused on evaluating the effectiveness and efficacy of the dietary component as part of a comprehensive pediatric weight management intervention offered in a clinical setting.
Director, HealthWorks!, Center for Better Health and Nutrition, Heart Institute
Hoelscher DM, Kirk S, Cunningham-Sabo L, Ritchie L. Position of the Academy of Nutrition and Dietetics: Interventions for the prevention and treatment of pediatric overweight and obesity. Journal of the Academy of Nutrition and Pediatrics. 2013 (In press).
Hampl S, Demeule M, Eneli I, Frank M, Hawkins MJ, Kirk S, Sallinen B, Santos M, Schmidt A, Ward W, Rhodes S. Parent perspectives on attrition from tertiary care pediatric weight management programs. Clinical Pediatrics. 2013; 52(6):509-515.
Kirk S, Brehm B, Saelens BE, Woo JG, Kissel E, D’Alessio D, Bolling C, Daniels SR. Role of carbohydrate modification in weight management among obese children: A randomized clinical trial. Journal of Pediatrics. 2012; 161(2): 320-327.
Beebe DW, Miller N, Kirk S, Daniels SR, Amin R. The association between obstructive sleep apnea and dietary choices among obese individuals during middle to late childhood. Sleep Medicine. 2011; 12(8):797-799.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Amin R, Hiscock H, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross- sectional study. Sleep. 2011; 34(7):891-898.
Siegel RM, Neidhard MS, Kirk S. A comparison of low glycemic index and staged portion-controlled diets in improving BMI of obese children in a pediatric weight management program. Clinical Pediatrics. 2011; 50(5):459-461.
Kirk S, Bolling C. Practical Strategies in a Clinical Setting for Promoting Lifestyle Changes in Overweight Youth. Obesity Management. December 2007; 3(6):272-282.
Lawson ML, Kirk S, Mitchell T, Chen MK, Loux TJ, Daniels SR, Harmon CM, Clements RH. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multi-center study from the Pediatric Bariatric Study Group. Journal of Pediatric Surgery. 2006; 41(1):137-43.
Kirk S, Scott B, Daniels SR. Supplement to the Journal: Pediatric obesity epidemic: Treatment options. Journal of the American Dietetic Association. 2005; 105(5 Suppl 1):S44-51.
Kirk S, Zeller MH, Claytor R, Santangelo M, Khoury PR, Daniels SR. The relationship of health outcomes to improvement in body mass index in children and adolescents. Obes Res. 2005; 13:876-882.
Timothy K. Knilans, MD Director, Clinical Cardiac Electrophysiology and Pacing
is a clinical cardiac electrophysiologist with a large clinical practice in management of arrhythmia and syncope. He has extensive experience in non-invasive electrocardiographic methods and invasive therapeutic modalities including catheter and surgical ablation and implanted electrical device therapy. His research interests center on evaluation and treatment of syncope and prevention of sudden cardiac death.
Director, Clinical Cardiac Electrophysiology and Pacing
Cardiac electrophysiology and pacing; radio frequency ablation; tilt table testing
Cardiac arrest; sudden cardiac death
Czosek RJ, Anderson JB, Marino BS, Mellion K, Knilans TK. Noninvasive risk stratification techniques in pediatric patients with ventricular preexcitation. Pacing Clin Electrophysiol. 2011 May;34(5):555-62.
Eghtesady P, Michelfelder EC, Knilans TK, Witte DP, Manning PB, Crombleholme TM. Fetal surgical management of congenital heart block in a hydropic fetus: Lessons learned from a clinical experience. J Thorac Cardiovasc Surg. 2011 Mar;141(3):835-7.
Czosek RJ, Anderson J, Marino BS, Connor C, Knilans TK. Linear lesion cryoablation for the treatment of atrioventricular nodal re-entry tachycardia in pediatrics and young adults. Pacing Clin Electrophysiol. 2010 Nov;33(11):1304-11.
Mays WA, Border WL, Knecht SK, Gerdes YM, Pfriem H, Claytor RP, Knilans TK, Hirsch R, Mone SM, Beekman RH 3rd. Exercise capacity improves after transcatheter closure of the Fontan fenestration in children. Congenit Heart Dis. 2008 Jul;3(4):254-61.
Knecht SK, Mays WA, Gerdes YM, Claytor RP, Knilans TK. Exercise evaluation of upper- versus lower-extremity blood pressure gradients in pediatric and young-adult participants. Pediatr Exerc Sci. 2007 Aug;19(3):344-8.
Wright KN, Knilans TK, Irvin HM. When, why, and how to perform cardiac radiofrequency catheter ablation. J Vet Cardiol. 2006 Nov;8(2):95-107.
Knilans TK. Multielectrode coronary artery catheterization: still an effective tool in ablation of right free-wall accessory pathways. J Cardiovasc Electrophysiol. 2004 Nov;15(11):1244-5.
Markham LW, Knecht SK, Daniels SR, Mays WA, Khoury PR, Knilans TK. Development of exercise-induced arm-leg blood pressure gradient and abnormal arterial compliance in patients with repaired coarctation of the aorta. Am J Cardiol. 2004 Nov 1;94(9):1200-2.
Beery TA, Dyment M, Shooner K, Knilans TK, Benson DW. A candidate locus approach identifies a long QT syndrome gene mutation. Biol Res Nurs. 2003 Oct;5(2):97-104.
Catherine Dent Krawczeski, MD Director, Quality Improvement & Clinical Effectiveness
is a pediatric cardiac intensivist who has special interests in outcomes after pediatric heart surgery and in quality improvement. Her research focuses on the effects of cardiopulmonary bypass on the kidney and the discovery and validation of early biomarkers of acute kidney injury. She also directs quality improvement for the Heart Institute, focusing on improving outcomes, safety, flow, and family satisfaction.
Director, Quality Improvement & Clinical Effectiveness
Co-Director, Center for Acute Care Nephrology
Cardiac intensive care; heart failure; heart transplantation; pulmonary hypertension; single ventricle physiology
Acute kidney injury after cardiopulmonary bypass; urinary biomarkers of renal ischemia; intensive care outcomes; cardiopulmonary bypass mediated injury
Catherine Krawczeski MD is an associate professor of pediatrics with the University of Cincinnati College of Medicine and is clinical faculty in the Cardiac Intensive Care Unit. She is the director of Quality Improvement and Clinical Effectiveness for the Heart Institute and a co-director of the Center for Acute Care Nephrology.
Dr. Krawczeski received her medical degree from the University of Missouri and completed pediatric residency at Washington University/St. Louis Children’s Hospital and fellowships in pediatric cardiology and pediatric critical care medicine at the same institution. She is board certified in both specialties. Dr. Krawczeski has been on staff at Cincinnati Children’s Hospital since 2001.
Dr. Krawczeski focuses her research on clinical outcomes after pediatric cardiac surgery. She has a particular interest in the effects of cardiopulmonary bypass on the kidney. She has had a close collaboration with Prasad Devarajan, director of the division of Nephrology, translating biomarker technology to the bedside for early diagnosis of acute kidney injury (AKI) after cardiopulmonary bypass. Their successful discovery and validation of early AKI biomarkers, such as NGAL, has set the stage for future studies of potential therapeutic interventions. This collaboration has been further strengthened by the recent creation of the Center for Acute Care Nephrology (CACN), a joint effort by the Heart Institute and the division of Nephrology for the purpose of coordinating clinical care and AKI translational and clinical research.
Dr. Krawczeski also has an interest in Quality Improvement. She has been instrumental in creating Heart Institute “dashboards” to track outcomes and determine strategic improvement priorities. She collaborates closely with the Anderson Center to facilitate improvement initiatives within the Heart Institute.
Krawczeski CD, Goldstein SL, Woo, JG, Wang Y, Piyaphanee N, Ma Q, Bennett M, Devarajan P. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol. 2011 Nov 22;58(22):2301-2309.
Zappitelli M, Krawczeski C, Devarajan P, Wang Z, Sint K, Thiessen-Philbrook H, Li S, Bennett M, Ma Q, Shlipak M, Garg A, Parikh C for the TRIBE-AKI Consortium. Early post-operative serum cystatin C predicts severe AKI after pediatric cardiac surgery: a multi-center prospective study. Kidney International. 2011, Sept;80:6555-662.
Parikh CR, Coca SG, Devarajan P, Shlipak MG, Thiessen-Philbrook H, Edelstein CL, Wang Z, Zappitelli M, Koyner J, Krawczeski CD, Patel UD, Swaminathan M, Passik CS, Garg AX; for the TRIBE-AKI Consortium. Post-operative biomarkers predict acute kidney injury and poor outcomes after cardiac surgery. J Am Soc Nephr. 2011, Sept;22:1748-1757.Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim R, Koyner J, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD; for the TRIBE-AKI Consortium. Early post-operative urine and serum biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephr. 2011, Sept;22:1737-1747.
Krawczeski CD, Woo JG, Wang Y, Bennett MR, Ma Q, Devarajan P. Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr. 2011 Jun;158(6):1009-1015.e1Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray J, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Marthing C-R, Venge P, Siew E, Ware LB, Ikizler A, Mertens PR. The outcome of neutrophil gelatinase-associated lipocalin (NGAL)-positive subclinical acute kidney injury: A multi-center pooled analysis of prospective studies. J Am Coll Cardio. 2011 Apr;57:1752-1761Krawczeski CD, Vandevoorde RG, Kathman T, Bennett MR, Woo JG, Wang Y, Griffiths RE, Devarajan P. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin J Am Soc Nephrol. 2010 Sep;5(9):1552-7.
Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt FC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro, C, Kanter KR, Jaggars J, Jacobs J, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW; for the Pediatric Heart Network Investigators. Outcomes of the Norwood procedure in infants randomized to a modified Blalock-Taussig versus right ventricle-to-pulmonary artery shunt. New Engl J Med. 2010 May;362:1980-92.
Dent CL, Ma Q, Dastrala S, Bennett M, Mistnefes M, Barasch J, Devarajan P. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity, and mortality after cardiac surgery: a prospective study. Criti Care. 2007 Dec;11(6):R127
Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, Pearl JM, Khoury PR, Kurth CD. Brain magnetic resonance imagining abnormalities following the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovas Surg. 2006 Jan;131(1):190-197.
Biomarkers of renal injury in cardiac surgery. Co-Investigator. National Heart, Lung, and Blood Institute. Jul 2007 - Jun 2012.
Phase II/III double blind, randomized, placebo controlled, clinical trial to determine the safety and efficacy of intravenous L-citrulline versus placebo in children undergoing cardiopulmonary bypass. Primary Investigator. Asklepion Pharmaceuticals. Feb 2008 - Dec 2012.
Progression of acute kidney injury to chronic kidney disease. Co-Investigator. National Institutes of Health. Jan 2009 - Dec 2013.
Outcomes after single ventricle reconstruction in children with hypoplastic left heart syndrome and other single right ventricle anomalies. Primary Investigator. National Institutes of Health. Jun 2008 - Dec 2015.
Andreas W. Loepke, MD, PhD Staff Anesthesiologist, Division of Cardiac Anesthesia
Staff Anesthesiologist, Division of Cardiac Anesthesia
Associate Professor, UC Department of Anesthesia
Anesthesia for neonates; congenital heart surgery; single-ventricle physiology
Visit the Loepke Lab.
Andreas W. Loepke, MD, PhD, has been practicing pediatric cardiac anesthesiology since 2000, first at the Children's Hospital of Philadelphia, and since 2003 at Cincinnati Children's Hospital Medical Center.
Dr. Loepke’s research laboratory investigates the potential use of anesthetics for neurological protection during brain ischemia as well as their possible adverse effects on brain development. His research group discovered in animals that anesthetics differentially affect brain regions, dependent on the age during exposure. Related to these findings, his lab made the discovery that neurons are susceptible to the anesthetics’ toxic effects during a specifically vulnerable stage of their development.
MD: University of Dusseldorf, Germany, 1993.PhD: University of Dusseldorf, Germany, 1995.
Internship: General Surgery, Pennsylvania Hospital, Philadelphia, PA, 1996.Residency: Anesthesiology, Thomas Jefferson Medical College, Philadelphia, PA, 1999.Fellowship: Pediatric Anesthesia and Pediatric Cardiac Anesthesia, Children's Hospital of Philadelphia, Philadelphia, PA, 2000.Certification: Anesthesiology, 2000.Maintenance of Certification: Anesthesiology, 2010.
Hofacer RD, Deng M, Ward CG, Joseph B, Hughes EA, Jiang C, Danzer SC, Loepke AW. Cell-age specific vulnerability of neurons to anesthetic toxicity. Ann Neurol. 2013.
Istaphanous GK, Ward CG, Nan X, Hughes EA, McCann JC, McAuliffe JJ, Danzer, SC, Loepke AW. Characterization and Quantification of Isoflurane-Induced Developmental Apoptotic Cell Death In Mouse Cerebral Cortex. Anes Analg. 2013; 116(4): 845-54.
Mintz CD, Wagner M, Loepke AW. Preclinical research into the effects of anesthetics on the developing brain: promises and pitfalls. J Neurosurg Anesthesiol. 2012; 24(4): 362-7.
Istaphanous GK, Howard J, Nan X, Hughes EA, McCann JC, McAuliffe JJ, Danzer SC, Loepke AW. Comparison of the Neuroapoptotic Properties of Equipotent Anesthetic Concentrations of Desflurane, Isoflurane, or Sevoflurane in Neonatal Mice. Anesthesiology. 2011; 114(3): 578-87.
Loepke AW. Developmental Neurotoxicity of Sedatives and Anesthetics – A Concern For Neonatal and Pediatric Critical Care Medicine? Pediatr Crit Care Med. 2010; 11(2): 217-226.
McAuliffe JJ, Loepke AW, Miles L, Joseph B, Hughes E, Vorhees CV. Desflurane, Isoflurane and Sevoflurane Provide Limited Neuroprotection Against Neonatal Hypoxia-Ischemia in a Delayed-Preconditioning Paradigm. Anesthesiology. 2009; 111(3): 533-46.
Loepke AW, Istaphanous GK, McAuliffe JJ, Miles L, Hughes EA, McCann JC, Harlow KE, Kurth CD, Williams MT, Vorhees CV, Danzer SC. The Effects of Neonatal Isoflurane Exposure in Mice on Brain Cell Viability, Adult Behavior, Learning, and Memory. Anesth Analg. 2009; 108(1): 90-104.
Loepke AW, Soriano SG. An Assessment of the Effects Of General Anesthetics on Developing Brain Structure and Neurocognitive Function. Anesth Analg. 2008; 106: 1681-1707.
Loepke AW, McCann JC, Kurth CD, McAuliffe JJ. Physiologic Effects of Isoflurane Anesthesia in Neonatal Mice. Anesth Analg. 2006; 102: 75-80.
Loepke AW, Priestley MA, Schultz SE, McCann JC, Kurth CD. Desflurane Improves Outcome After Low-Flow Cardiopulmonary Bypass in Newborn Pigs. Anesthesiology. 2002; 97: 1521-7.
Bradley S. Marino, MD, MPP, MSCE Attending Cardiac Intensivist, Cardiac Intensive Care Unit
is a pediatric cardiologist who focuses on outcomes in infants, neonates, children and adolescents with complex congenital heart disease (CHD). He has specifically focused his research efforts on the impact of neurodevelopmental, psychosocial, and physical morbidities on quality of life, functional status and behavioral and emotional outcomes in the high-risk complex CHD population.
Director, Heart Institute Research Core
Director, Heart Institute Neurodevelopmental Clinic
Cardiac intensive care; single ventricle physiology; aortic and mitral valve disease; cardiopulmonary interaction
Intensive care outcomes; quality of life assessment in children and adolescents with congenital and acquired heart disease; aortic valve and mitral valve surgical outcomes; cardiopulmonary interaction (shock and cardiac arrest).
Bradley S. Marino, MD, MPP, MSCE is an Associate Professor of Pediatrics with the University of Cincinnati College of Medicine and an attending cardiac intensivist in Cincinnati Children’s Hospital Medical Center’s (CCHMC) Cardiac Intensive Care Unit. Dr. Marino is also currently the Director of the Heart Institute Research Core and the Director of Heart Institute Neurodevelopmental Clinic at CCHMC.
A native of New York, Dr. Marino graduated with Honors from University of Virginia and earned his medical degree from Harvard Medical School in 1994. He completed his pediatric residency at Johns Hopkins Hospital and a combined fellowship in Cardiology and Critical Care Medicine at The Children’s Hospital of Philadelphia. Dr. Marino’s clinical interests are focused on outcomes in infants, neonates, children, and adolescents with complex congenital heart disease (CHD). In addition Dr. Marino received a Master’s degree in Public Policy from the John F. Kennedy School of Government at Harvard University in 1994 and a Master’s of Science degree in Clinical Epidemiology from the Center for Clinical Epidemiology and Biostatistics at University of Pennsylvania in 2005.
Dr. Marino has been a faculty member in the divisions of Cardiology and Critical Care Medicine at CCHMC since 2007. Upon his arrival, he led the development of HIRC, an innovative platform that supports clinical and translational science by facilitating the design of research processes, implementation of research plans, dissemination and application of findings, and development of research professionals. HIRC presently provides support to more than 75 principal investigators on 180 clinical and translational research projects.
Dr. Marino has focused his own research efforts on the impact of neurodevelopmental, psychosocial, and physical morbidities on quality of life, functional status, and behavioral and emotional outcomes in the high-risk complex congenital heart disease population. He is the creator of the Pediatric Cardiac Quality of Life Inventory (PCQLI), a validated disease-specific health-related quality of life tool and was awarded several intramural and extramural training grants to test the psychometric properties of the PCQLI in the multi-center, multi-national PCQLI Validation Study in the United States and the United Kingdom. To address the lower quality of life associated with patients with severe heart disease, Dr. Marino spearheaded the creation of the Heart Institute Neurodevelopmental Clinic (NDC) in 2011. The NDC multi-disciplinary team consists of cardiologists, cardiovascular geneticists, neurologists, developmental pediatricians, psychologists, educators, occupational therapists, nutritionists, and social workers who address neurodevelopmental issues that impact learning, psychological and social functioning and physical functioning. It is one of few clinics of its kinds in the US for “high-risk” children with heart disease.
Dr. Marino’s expertise in the field of outcomes research in pediatric cardiology has led to many presentations, publications, and invitations to serve on national expert committees including American Heart Association’s Emergency Cardiac Care Pediatric Subcommittee and Pediatric Cardiac Intensive Care Society Board of Directors. Dr. Marino has been recognized in Cincy Magazine: Best Doctors in America – Pediatric Cardiology Pediatric Critical Medicine in 2008, 2009, 2010 and 2011.
MD: Harvard Medical School, Boston, MA, 1994.
MPP: Harvard University/John F. Kennedy School of Government (Masters in Public Policy - Health Care Policy), Boston, MA, 1994.
MSCE: University of Pennsylvania/Center for Clinical Epidemiology and Biostatistics, (Master of Science in Clinical Epidemiology), Philadelphia, PA, 2005.
Residency: Pediatrics, Johns Hopkins Hospital, Baltimore, MD, 1997.
Fellowships: Combined Pediatric Cardiology and Pediatric Critical Care Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, 2002.
Certification:American Board of Pediatrics 1997, Recertification 2004;Sub-Board of Pediatric Cardiology 2000;Sub-Board of Pediatric Critical Care Medicine 2002.
Goldberg D, French B, Szwast AL, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J. Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation. Pediatric Cardiology 2012 (In Press)
Anderson J, Czosek RJ, Uzark K, Knilans TK, Marino BS. The effect of pediatric syncope on quality of life. Cardiol Young 2012 (In Press)
Wray J, Franklin R, Brown K, Blyth J, Marino BS. Linguistic validation of a disease-specific quality of life measure for children and teenagers with cardiac disease. Cardiol Young 2012; 22(1):13-17.
Wray J, Brown K, Rodney F, Marino BS. Medical test results don’t tell the whole story: health-related quality of life offers a patient perspective on outcomes. WJPCHS2011; 2(4):566-575.
Metzger A, Matsuura T, McKnite S, Marino BS, Nadkarni V, Lurie K, Yannopoulos D. Intrathoracic pressure regulation improves 24-hour survival in a pediatric porcine model of hemorrhagic shock. Pediatric Research 2011; 70(3):267-271.
Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SA, Rychik J. Impact of oral sildenafil on exercise performance in children and young adults after Fontan operation: a randomized, double-blind, placebo controlled, crossover trial. Circulation 2011; 123:1185-1193.
Anderson JB, Kalkwarf HJ, Kehl JE, Eghtesady P, Marino BS. Low weight-for-age Z-score and infection risk following Fontan procedure. Annals Thorac Surg 2011; 91(5):1460-1466.
Anderson JB, Marino BS, Irving SY, García-España JF, Ravishankar C, Stallings VA, Medoff-Cooper B. Poor post-operative growth in infants with two-ventricle physiology. Cardiol Young. 2011 Mar 9:1-9. Anderson JB, Kalkwarf HJ, Kehl JE, Eghtesady P, Marino BS. Low Weight-for-Age Z-Score and Infection Risk After the Fontan Procedure. Ann Thorac Surg. 2011 Mar 4.
Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SA, Rychik J. Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After Fontan Operation: A Randomized, Double-Blind, Placebo Controlled, Crossover Trial. Circulation. 2011 Mar 7.
Marino BS, Drotar D, Cassedy A, Davis R, Tomlinson RS, Mellion K, Mussatto K, Mahony L, Newburger JW, Tong E, Cohen MI, Helfaer MA, Kazak AE, Wray J, Wernovsky G, Shea JA, Ittenbach R. External Validity of the Pediatric Cardiac Quality of Life Inventory. Quality of Life Research. 2011 Mar;20(2):205-14.
Manning PB, Rutter MJ, Lisec A, Gupta R, Marino BS. One slide fits all: the versatility of slide tracheoplasty with cardiopulmonary bypass support for airway reconstruction in children. J Thorac Cardiovasc Surg. 2011 Jan;141(1):155-61.
Marino BS, Tomlinson RS, Wernovsky G, Drotar D, Newburger JW, Mahony L, Mussatto K, Tong E, Cohen M, Andersen C, Shera D, Khoury P, Wray J, Gaynor WJ, Helfaer MA, Kazak AE, Shea JA. Evaluation of Health-related Quality of Life in Children and Adolescents with Congenital or Acquired Heart Disease: Validation of the Pediatric Cardiac Quality of Life Inventory. Pediatrics. 2010;126:1-11. Kleinman ME, Chameides L, Schexnayder SM, Samson RA, Hazinski MF, Atkins DL, Berg MD, de Caen A, Fink E, Freid E, Hickey R, Marino BS, Nadkarni VM, Proctor L, Qureshi F, Sartorelli K, Topjian A, van der Jagt E, Zaritsky AL. Pediatric Advance Life Support. Circulation. 2010;122(18 Suppl 3):S876-S908. Marino BS, Tomlinson RS, Drotar D, Claybon ES, Aguirre A, Ittenbach R, Welkom JS, Helfaer MA, Wernovsky G, Shea JA. Quality-of-life concerns differ among patients, parents, and medical providers in children and adolescents with congenital and acquired heart disease. Pediatrics. 2009;123(4):e708-15. Marino BS, Shera D, Wernovsky G, Tomlinson RS, Aguirre A, Gallagher M, Lee A, Cho C, Stern W, Davis L, Tong E, Teitel D, Mussatto K, Ghanayem N, Gleason, M, Gaynor JW, Wray J, Helfaer MA, Shea JA. The development of the Pediatric Cardiac Quality of Life Inventory: a quality of life measure for children and adolescents with heart disease. Quality of Life Research. 2008;17(4):613-626. Marino BS, Kruge LE, Cho CJ, Tomlinson RS, Shera D, Weinberg PM, Gaynor JW, Rychik J. Parachute mitral valve: morphologic descriptors, associated lesions, and outcomes after biventricular repair. J Thorac Cardiovasc Surg. 2008;137:385-393.
Outcomes Research in Children with Complex Congenital Heart Disease. Principal Investigator. Cincinnati Children’s Hospital Research Foundation. 7/1/07-6/30/12
Do Serum Biochemical and Hematopoietic, and Stool Biomarkers Predict Low Cardiac Index in Patients with Fontan Physiology? Principal Investigator. Children’s Heart Foundation. 1/1/12-12/31/13
Transitional Telehealth Home Care: REACH. Site Principal Investigator. National Institute of Nursing Research. 9/21/11-6/30/16
Understanding Mechanisms of Fontan Failure and Key Predictors for Patient Outcome. Collaborator. NIH/NHLBI. 2/01/10-1/31/14
Erik C. Michelfelder, MD Director of the Fetal Cardiac Program
is a clinical cardiologist who has clinical research programs in fetal cardiology and echocardiography. Within the Fetal Heart Program, the fetal echocardiography lab studies anatomic and physiologic predictors of cardiac function, perinatal physiology, and clinical outcomes in fetuses with both structural and function cardiovascular abnormalities. General echocardiographic research conducted by Dr. Michelfelder also included echocardiographic assessment of cardiac systolic and diastolic function in infants, children, and young adults with a variety of structural and function cardiac abnormalities.
Director of the Fetal Cardiac Program
Co-Director of Cardiac Imaging
Erik C. Michelfelder Sr., MD is an Associate Professor of Pediatrics with the University of Cincinnati College of Medicine. He is currently Director of the Fetal Heart Program, and Co-Director of Cardiac Imaging Services for the Heart Institute at Cincinnati Children’s Hospital Medical Center.
Dr. Michelfelder graduated with a degree in Biology from Bucknell University and earned his M.D. from the Penn State University College of Medicine. He completed his residency in pediatrics at St. Christopher’s Hospital for Children in Philadelphia, and his cardiology fellowship at C.S. Mott Children’s Hospital at the University of Michigan in Ann Arbor.
Dr. Michelfelder has been a member of the Division of Cardiology at Cincinnati Children’s Hospital Medical Center since 1998. His clinical and academic focus relate to fetal cardiology and echocardiography.
He is a member of the American Society of Echocardiography, The American Heart Association, The American College of Cardiology, The American Academy of Pediatrics, and the Society for Pediatric Research.
BS: Bucknell University, Lewisburg, PA, 1986.
MD: Penn State University College of Medicine, Hershey, Pennsylvania, 1990.Residency: St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania, 1990-1993.Fellowship: C.S. Mott Children's Hospital, University of Michigan Medical Center, Ann Arbor, Michigan, 1993-1996.Certification: Pediatrics 1991, Pediatric Cardiology 1998.
Divanovic A, Hor K, Cnota JF, Hirsch R, Kinsel-Ziter M, Michelfelder EC. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: clinical experience using pulmonary venous Doppler analysis. Journal of Thoracic and Cardiovascular Surgery. [in press]
Divanović A, Hor K, Cnota J, Hirsch R, Kinsel-Ziter M, Michelfelder E. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: Clinical experience using pulmonary venous Doppler analysis. J Thorac Cardiovasc Surg. 2010 Dec 2.
Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation. Am J Obstet Gynecol. 2010 Oct;203(4):397.e1-9.
Habli M, Cnota J, Michelfelder E, Salisbury S, Schnell B, Polzin W, Lim FY, Crombleholme TM. The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2010 Oct;203(4):404.e1-7.
Boat A, Mahmoud M, Michelfelder EC, Lin E, Ngamprasertwong P, Schnell B, Kurth CD, Crombleholme TM, Sadhasivam S. Supplementing desflurane with intravenous anesthesia reduces fetal cardiac dysfunction during open fetal surgery. Paediatr Anaesth. 2010 Aug;20(8):748-56.
Hinton RB, Michelfelder EC, Marino BS, Bove KE, Ware SM. A fetus with hypertrophic cardiomyopathy, restrictive, and single-ventricle physiology, and a beta-myosin heavy chain mutation. J Pediatr. 2010 Jul;157(1):164-6. Epub 2010 Apr 14.
Kinsel-Ziter ML, Cnota JF, Crombleholme TM, Michelfelder EC. Twin-reversed arterial perfusion sequence: pre- and postoperative cardiovascular findings in the 'pump' twin. Ultrasound Obstet Gynecol. 2009 Nov;34(5):550-5.
Michelfelder E, Polzin W, Hirsch R. Hypoplastic left heart syndrome with intact atrial septum: Utilization of a hybrid catheterization facility for cesarean section delivery and prompt neonatal intervention. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):983-7.
Habli M, Michelfelder E, Livingston J, Harmon J, Lim FY, Polzin W, Crombleholme T. Acute effects of selective fetoscopic laser photocoagulation on recipient cardiac function in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2008 Oct;199(4):412.e1-6.
Shah AD, Border WL, Crombleholme TM, Michelfelder EC. Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome. J Am Soc Echocardiogr. 2008 Oct;21(10):1105-8.
Robert M. Siegel, MD, FAAP Medical Director, Center for Better Health and Nutrition
Medical Director, Center for Better Health and Nutrition
Pediatric obesity prevention and treatment
Robert M. Siegel is a professor of Clinical Pediatrics at the University of Cincinnati and medical director of the Center for Better Health and Nutrition of the Heart Institute. He graduated Magna cum laude from Hunter College of the City University of New York and earned his MD from New York University. Dr. Siegel did his pediatric residency at Cincinnati Children’s Hospital. He was a general pediatrician for more than twenty years before joining the Heart Institute and was president of the Medical Staff at Cincinnati Children’s from 2008 to 2010. Dr. Siegel’s research interests include dietary and physical activity interventions in obese children.
MD: New York University, School of Medicine, New York, NY, 1984.
Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1984-87.
Fellowship: Infectious Diseases, Cincinnati Children’s Hospital Medical Center, 1992. American Board of Pediatrics, 1988.
Certification: Pediatrics, 1988.
Kanetzke EE, Lynch J, Prows CA, Siegel RM, Myers MF. Perceived Utility of Parent-Generated Family Health History as a Health Promotion Tool in Pediatric Practice. Clinical Pediatrics. 2011;50:720-8.
Siegel RM, Neidhard MS, Kirk S. A Comparison of Reduced Glycemic Load and Staged Portion-Controlled Diets in Improving BMI and Other Health Outcomes of Obese Children in a Pediatric Weight Management Program. Clinical Pediatrics. 2011;50:459-461.
Siegel RM, Rich W, Khoury J. An Office-Based Low Carbohydrate Intervention in Teens: One Year Follow-up of a Six-Month Intervention. Clinical Pediatrics. 2011;50:459-461.
Siegel RM. Acute Otitis Media Guidelines, Antibiotic Use, and Shared Medical Decision-Making. Pediatrics. 2010;125:384–386.
Siegel RM, Rich W, Joseph EC, Linhardt J, Knight K, Khoury J, Daniels SR. A Six Month Office-Based Low Carbohydrate Diet Intervention in Obese Teens. Clinical Pediatrics. 2009;48:745-749.
Siegel RM, Scubiner J, Samarmco VJ. A non-operative technique for peroneal tendon subluxation. Clinical Pediatrics. 2008;47(3):300-1.
Olson L, Radecki L, Frinter MP, Weiss K, Siegel R. At what age can children report their asthma health status? Pediatrics. Jan 2007;119:e93-e102.
Siegel RM, Bien J, Lichtenstein P, Davis J, Khoury J, Knight J, Kiely M, Bernier J. A safety-net prescription for otitis media: the effects of a PBRN study on patients and practitioners. Clinical Pediatrics. 2006;45:518-524.
Zink T, Siegel RM, Chen L, Levin L, Pabst S, Putnam F. Physician Knowledge and Management of Children Exposed to Domestic Violence in Ohio: A Comparison of Pediatricians and Family Physicians. Clinical Pediatrics. 2005;44:211-219b.
Siegel RM. Antibiotics and acute otitis media: Reducing overuse and drug resistance. Fam Prac Recertification. 2004;26:92-97.
James P. Spaeth, MD Director, Cardiac Anesthesia
is a pediatric cardiac anesthesiologist and the Director of Cardiac Anesthesia. His clinical research interests include the effect of congenital cardiac disease and cardiac surgery on neurodevelopmental outcomes, and the use of cerebral monitoring during the perioperative period. He is also involved in Quality Improvement work focused on improving the safety of pediatric anesthesia.
Director, Cardiac Anesthesia
MD: University of Virginia School of Medicine, Charlottesville, VA, 1993.
Internship: Internal Medicine, University of Virginia Medical Center, Charlottesville, VA, 1994.
Residency: Anesthesiology, University of California, San Diego Medical Center, San Diego, CA, 1997.
Fellowship: Pediatric Anesthesiology, Children's Hospital of Philadelphia, Philadelphia, PA, 1998.
Certification: Anesthesiology, 1998.
Gunter JB, McAuliffe JJ, Beckman EC, Wittkugel EP, Spaeth JP, Varughese AM. A factorial study of ondansetron, metoclopramide, and dexamethasone for emesis prophylaxis after adenotonsillectomy in children. Paediatr Anaesth. 2006 Nov;16(11):1153-65.
Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, Pearl JM, Khoury PR, Kurth CD. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2006 Jan;131(1):190-7. Aronson LA, Spaeth JP. Frontiers in pediatric anesthesia: cardiac anesthesia. Int Anesthesiol Clin. 2006 Winter;44(1):33-49. Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, Pearl JM, Khoury PR, Kurth CD. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2005 Dec;130(6):1523-30.
Loepke AW, Spaeth JP. Glucose and Heart Surgery: Neonates Are Not Just Small Adults. Anesthesiology. 2004 Jun;100(6):1345-52.Baker RC, Schubert CJ, Kirwan KA, Lenkauskas SM, Spaeth JT. After-hours telephone triage and advice in private and nonprivate pediatric populations. Arch Pediatr Adolesc Med. 1999 Mar;153(3):292-6.
Michael D. Taylor, MD Director, Advanced Imaging Innovation
is a non-invasive cardiologist interested in applications of imaging to problems of congenital and acquired heart disease. His primary research interest is cardiac MRI and its application in evaluating myocardial function and disease. He has a translational program that uses multi-modality imaging to characterize mouse models of inherited and acquired cardiomyopathies.
Director, Advanced Imaging Innovation
Cardiac MRI; Cardiac CT; and echocardiography
Myocardial metabolism; animal models of heart failure; positron emission tomography
Michael Taylor, MD joined the Heart Institute in July, 2010 as the director of Advanced Imaging Innovation. He was previously the director of cardiac magnetic resonance at Texas Children’s Hospital in Houston.
Dr. Taylor has expertise in cardiac magnetic resonance imaging, positron emission tomography and computed tomography. He has a dual appointment in the Cincinnati Children's Hospital Medical Center Imaging Research Center, an interdisciplinary facility of advanced imaging faculty with dedicated clinical and pre-clinical imaging equipment.
Dr Taylor's primary interests include myocardial metabolism in heart failure, animal models of cardiac pathology, and cardiac magnetic resonance imaging of congenital and acquired heart disease.
MD: University of Wisconsin, Madison, WI; 2001.PhD: Medical Physics, University of Wisconsin, Madison, WI; 2001.
Residency: Pediatrics, Baylor College of Medicine, Houston, TX; 2003.Fellowship: Pediatric Cardiology, Baylor College of Medicine, Houston, TX; 2006.Certification: Pediatrics; 2005.Certification: Pediatric Cardiology; 2006.
Mazur W, Hor KN, Germann JT, Fleck RJ, Al-Khalidi HR, Wansapura JP, Chung ES, Taylor MD, Jefferies JL, Woodrow Benson D, Gottliebson WM. Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. Int J Cardiovasc Imaging. 2011 Jan 8. Purevjav E, Varela J, Morgado M, Kearney DL, Li H, Taylor MD, Arimura T, Moncman CL, McKenna W, Murphy RT, Labeit S, Vatta M, Bowles NE, Kimura A, Boriek AM, Towbin JA. Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol. 2010 Oct 26;56(18):1493-502.
LP Browne, D Kearney, MD Taylor, T Chung, TC Slesnick, AC Nutting, R Krishnamurthy. ALCAPA: the role of myocardial viability studies in determining prognosis . Pediatr Radiol. 2010;40(2):163-167. JL Jefferies, MD Taylor, J Rossano, JW Belmont, WJ Craigen. Novel cardiac findings in periventricular nodular heterotopia . Am J Med Genet. 2009; 152A(1): 165-168. JW Rossano, MD Taylor, EO Smith, CD Fraser, ED McKenzie, JF Price, HA Dickerson, DP Nelson, AR Mott. Glycemic profile in infants who have undergone the arterial switch operation: hyperglycemia is not associated with adverse events . J Thorac Cardiovasc Surg. 2008; 135(4): 739-745.
Jeffrey A. Towbin, MD, FAAP, FACC, FAHA Executive Co-Director, Heart Institute; Chief, Pediatric Cardiology
is the Executive Co-Director of the Heart Institute and the Chief of Pediatric Cardiology at University of Cincinnati College of Medicine; he is a leading expert in cardiomyopathy and had authored numerous papers on cardiomyopathy and heart failure.
Executive Co-Director, Heart Institute; Chief, Pediatric Cardiology
UC Department of Pediatrics
BS: Biology, University of Cincinnati, 1974.MS: Cell Biology, University of Cincinnati, 1977.MD: University of Cincinnati, 1982.
Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, 1985.
Fellowship: Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, 1989.
McBride KL, Zender GA, Fitzgerald-Butt SM, Seagraves NJ, Fernbach SD, Zapata G, Lewin M, Towbin JA, Belmont JW. Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects. Birth Defects Res A Clin Mol Teratol. 2011 Mar;91(3):162-8.
Fakhro KA, Choi M, Ware SM, Belmont JW, Towbin JA, Lifton RP, Khokha MK, Brueckner M. Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2915-20.
Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2010 Dec 28;57(1):51-9.
Towbin JA, Ware SM, Jefferies JL. Heart transplants in pediatric patients: viral infection as a loss predictor. Future Cardiol. 2010 Nov;6(6):735-41.
Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, Kantor PF, Alvarez JA, Colan SD, Jefferies JL, Lamour JM, Margossian R, Messere JE, Rusconi PG, Shaddy RE, Towbin JA, Wilkinson JD, Lipshultz SE. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010 Nov 1;3(6):689-97.
Purevjav E, Varela J, Morgado M, Kearney DL, Li H, Taylor MD, Arimura T, Moncman CL, McKenna W, Murphy RT, Labeit S, Vatta M, Bowles NE, Kimura A, Boriek AM, Towbin JA. Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol. 2010 Oct 26;56(18):1493-502. Towbin JA. Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin. 2010 Oct;6(4):453-69 Towbin JA. Preface: Heart failure in children. Heart Fail Clin. 2010 Oct;6(4):xvii-iii.
Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Cox GF, Canter CE, Hsu DT, Webber SA, Lipshultz SE. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010 Oct;6(4):401-13 Towbin JA. Hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S23-31.
Elaine M. Urbina, MD, MS Director, Preventive Cardiology
is a pediatric preventive cardiologist who is interested in how CV risk factors affect vascular function. Her lab uses a variety of non-invasive techniques to measure how vascular structure (carotid intima-media thickness), arterial stiffness (pulse wave velocity) and endothelial function (brachial flow mediated dilation) are affected by a variety of pediatric diseases.
Director, Preventive Cardiology
Elaine M. Urbina, MD, graduated from the Medical College of Georgia in 1988. She subsequently trained in Pediatrics at the University of California at San Francisco. She completed her Pediatric Cardiology fellowship at Tulane University in New Orleans, Louisiana, in 1994 where she accepted an assistant professor position.
In addition to practicing clinical Pediatric Cardiology at Tulane, she was also director of Preventive Cardiology and the Pediatric Echocardiography Laboratory. Her research interests led her to join the world-renowned Bogalusa Heart Study, one of the longest running epidemiologic studies of CV risk factors in children. As co-investigator under the tutelage of Dr. Gerald S. Berenson, she initiated the non-invasive imaging program and supervised collection of CV data for over a decade.
Dr. Urbina joined Cincinnati Children's Hospital Medical Center as associate professor in October of 2003 and became director of Preventive Cardiology in 2006. This new opportunity allowed her to concentrate her clinical practice on the diagnosis and treatment of high blood pressure and cholesterol. She continues her research studies concentrating on non-invasive imaging methods to measure atherosclerosis with a focus on vascular function abnormalities using the modalities of:
Her current research includes the application of these new techniques to study the roles that pre- and post-natal nutrition, overweight, high blood pressure, cholesterol and diabetes play in the development of hardening of the arteries.
MD: Medical College of Georgia, Augusta, GA, 1988.
Residency: University of California, San Francisco, CA, 1990; Tulane University, New Orleans, LA 1991 (Pediatrics).
Fellowship: Tulane University, New Orleans, LA, 1994 (Pediatric Cardiology).
Certification: Pediatrics 1991; Pediatric Cardiology 1994.
Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). May 2011;13(5):332-342.
Urbina EM, Dolan LM, McCoy CE, Khoury PR, Daniels SR, Kimball TR. Relationship between elevated arterial stiffness and increased left ventricle mass in adolescents and young adults. J Pediatr. May 2011;158(5):715-721.
Urbina EM, Kimball TR, Khoury PR, Daniels SR, Dolan LM. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. Aug 2010;28(8):1692-1698.
Urbina EM, Wadwa RP, Davis C, Snively BM, Dolan LM, Daniels SR, Hamman RF, Dabelea D. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex. J Pediatr. May 2010;156(5):731-737.
Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. Jun 2009;119(22):2913-2919.
Urbina EM, Bean JA, Daniels SR, D’Alessio D, Dolan LM. Overweight and hyperinsulinemia provide individual contributions to comprises in brachial artery distensibility in healthy adolescents and young adults: brachial distensibility in children. J Am Soc Hypertens. Jun 2007;1(3):200-207.
Urbina EM, Kieltkya L, Tsai J, Srinivasan SR, Berenson GS. Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: The Bogalusa Heart Study. Am J Hypertens. Jun 2005;18:767-771.
Urbina EM, Srinivasan SR, Kieltyka RL, Tang R, Bond MG, Chen W, Berenson GS. Correlates of carotid artery stiffness in young adults: The Bogalusa Heart Study. Atherosclerosis. Sep 2004;176(1):157-164.
Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults: The Bogalusa Heart Study. Am J Cardiol. Nov 2002;90(9):953-958.
Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity and blood pressure of the left ventricular growth in children and young adults in Bogalusa Heart Study. Circulation. May 1995;91(9):2400-2406.
Accelerated CV Aging in Youth Related to CV Risk Factor Clusters. Principal Investigator. National Heart, Lung and Blood Institute. Jan 2011-Dec 2016.
SEARCH 3: Cohort Study - Ohio site. Co-Investigator. Centers for Disease Control & National Institutes of Health. Sept 2010-Oct 2015.
Cardiovascular Effects of Dietary Fat & Exercise Challenges in Obese Children. Collaborator. National Heart, Lung and Blood Institute. June 2008-May 2013.
Modifying Dietary Behavior in Adolescents with Elevated Blood Pressure. Co-Investigator. Natonal Heart, Lung and Blood Institute. Dec 2007-Nov 2012.
Gruschen R. Veldtman, FRCP, MBChB Director of Inpatient ACHD Services, Heart Institute
is a clinician scientist who conducts research in the areas of single ventricle and Fontan physiology and pathophysiology; Eisenmenger syndrome and arrhythmia; contractile reserve in tetralogy of Fallot; and hepatopathy in the Fontan circulation and heart failure.
Director of Inpatient ACHD Services, Heart Institute
Spectrum of adult congenital heart disease: the Fontan circulation; interventional cardiology; pregnancy cardiology; pulmonary hypertension in congenital heart disease
Gruschen R. Veldtman, FRCP, MBChB, is newly appointed in the Heart Institute at Cincinnati Children's Hospital Medical Center. His major achievement has been the establishment of patient and science centered clinical programs that serve adult patients with various complexity of congenital heart conditions. His major academic contributions have been in the field of liver disease as it relates to the Fontan circulation.
General Paediatrics and Neonates, Royal Hospital for Sick Children, Glasgow, 1995.
Paediatric Cardiology, Leeds General Infirmary, 1999.
Fellowship: Adult Congenital Heart Disease, Toronto 2000.
Research Fellowship: Hospital For Sick Children Toronto, 2001.
Fellowship: Adult Congenital Heart Disease, Mayo Clinic, 2002.
Fellowship: Paediatric Interventional Cardiology, 2003.
Ivan Wilmot, MD Heart Failure Staff Physician
focuses on care of children with advanced heart failure requiring mechanical circulatory support bridge to transplant; quality of life in children with heart failure, transplant, and mechanical circulatory support (MCS); and advanced strain imaging in evaluation of ventricular function in pediatric heart transplant patients.
Heart Failure Staff Physician
Heart failure, transplantation, and mechanical circulatory support.
Care of children with advanced heart failure requiring mechanical circulatory support bridge to transplant; quality of life in children with heart failure, transplant and mechanical circulatory support (MCS); advanced strain imaging in evaluation of ventricular function in pediatric heart transplant patients.
Ivan Wilmot, MD, graduated summa cum laude from Louisiana State University with a Bachelor's of Science in zoology.
In 1998 he began medical school at Emory University. His general pediatrics residency training took place at the Emory Affiliated Hospitals from 2002 to 2006. He completed his pediatric cardiology fellowship training from 2006 to 2009, and advanced fellowship in heart failure and transplant from 2009 to 2010.
His clinical and research interests focus on heart failure, cardiac transplantation and mechanical circulatory support (MCS).
BS: Louisiana State University, 1998.
MD: Emory University School of Medicine, Atlanta, GA, 2002.
Residency: Emory Affiliated Hospitals, Atlanta, GA, 2005; Chief Resident: Emory Affiliated Hospitals, Atlanta, GA, 2006.
Fellowship: Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, 2009.
Advanced Fellowship: Heart Failure and Transplant, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, 2010.
Certification: American Board of Pediatrics; American Board of Pediatrics Sub-board of Pediatric Cardiology.
Stapleton GE, Wilmot I, Suh EJ. Cardiac catheterisation of patients with common arterial trunk and transposition of the great arteries. Cardiol Young. 2012 Dec:22(6), 687–690.
Dadlani GH, Braley K, Perez-Colon E, Stapleton G, Crawford M, Turpin D, Wilmot I, Freire G, Decker J, Martinez R. Long-term management of patients with hypoplastic left heart syndrome: the diagnostic approach at All Children's Hospital. Cardiol Young. 2011 Dec:21 Suppl 2, 80–87.
Asante-Korang A, Jacobs JP, Ringewald J, Carapellucci J, Rosenberg K, McKenna D, McCormack J, Wilmot I, Gjeldmun A, Lopez-Cepero M, Sleasman J. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. Cardiol Young. 2011 Dec:21 Suppl 2, 124–132.
Wilmot I, Morales DL, Price JF, Rossano JW, Kim JJ, Decker JA, McGarry MC, Denfield SW, Dreyer, WJ, Towbin JA, Jeffries JL. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail. 2011 June:17(6), 487–494.
Perez-Colon E, Dadlani GH, Wilmot I, Miller M. Mesalamine-induced myocarditis and coronary vasculitis in a pediatric ulcerative colitis patient: a case report. Case Rep Peditr. 2011; 524364.
Sharef S, Coleman R, Rivenes S, Wilmot I, Altman C, Madden-Fuentes R, Salazar J. Stentless xenograft implantation in aortic position in a 7-year-old girl. Tex Heart Inst J. 2010; 37(3), 347–349.
Wilmot I, Kanter KR, Vincent RN, Berg AM, Mahle WT. OKT3 treatment in refractory pediatric heart transplant rejection. J Heart Lung Transplant. 2005 Nov;24(11):1793-7.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center